Serum is commonly treated with potassium periodate to destroy nonspecific inhibitors of influenza virus hemagglutination. We Certain strains of influenza virus are extremely sensitive to nonspecific,inhibitors in serum. These inhibitors cannot be removed by the use of heat, trypsin, or potassium periodate, individually or in combination, but they are reduced by receptordestroying enzyme (RDE) and are removed completely by treatment with dry ice (7).
Serum is commonly treated with potassium periodate to destroy nonspecific inhibitors of influenza virus hemagglutination. We have observed, however, that such treatment of serum without pre-existing inhibitor produced high titers of inhibitor against certain strains of influenza virus. Inhibitor was induced in the serum from several different animal species but not in hamster or mouse serum. Periodate treatment of serum albumin, fraction V, from several animals, including man, creates this inhibitor. Our data indicate that the inhibitor induced in the serum of various animal species differs in its mechanism of induction and in its resistance to receptor-destroying enzyme and trypsin. Hemagglutination by B/Singapore/3/64, B/Colorado/2/ 65, B/Georgia/1 /65, and B/Massachusetts/3/66 strains of influenza virus is inhibited by periodate-treated human serum at dilutions as high as 1:5,120 . The routine use of periodate treatment of serum in diagnostic and surveillance studies of influenza virus infections is not recommended.
Certain strains of influenza virus are extremely sensitive to nonspecific,inhibitors in serum. These inhibitors cannot be removed by the use of heat, trypsin, or potassium periodate, individually or in combination, but they are reduced by receptordestroying enzyme (RDE) and are removed completely by treatment with dry ice (7) .
When we were preparing and testing standardized lots of B/Singapore/3/64 influenza virus seed and specific rooster antiserum, we observed the apparent induction of nonspecific inhibitor by treatment of the serum with potassium periodate. While this study was in progress, Mascoli et al. (6) reported a similar phenomenon with chicken and human serum with the 1965 influenza B viruses.
The finding that periodate induces inhibitor is contrary to all other published studies on the elimination of nonspecific serum inhibitors. Potassium periodate has generally been considered to be an accepted method of removing nonspecific inhibitors (5) .
This report characterizes the induction and certain properties of this inhibitor.
MATERIALS AND METHODS
Viruses. All influenza virus strains used in this study were obtained from the Virus and Rickettsia Section of the National Communicable Disease Center, Atlanta, Ga. These seed viruses were passed in 10-day-old embryonated chicken eggs until satisfactory hemagglutination and infectivity titers were produced. The viruses either were stored frozen at -56.6 C or lyophilized and stored at 4 C.
Treatment of serum: Potassium periodate (K104).
We mixed one volume of phosphate-buffered saline (PBS) and two volumes of serum and maintained these mixtures at 56 C for 30 min. Then we added six volumes of 0.011 M K104 and the mixture was held at room temperature for 15 min. Six volumes of 1% glycerol in distilled water was added, and the mixture was maintained at room temperature for an additional 15 min. The required dilution was then prepared with PBS. RDE (cholera filtrate). RDE (four volumes) containing 100 units/ml and one volume of serum were mixed and incubated overnight in a water bath at 37 C. Then, three volumes of 2.5% sodium citrate was added, and the mixture was held at 56 C for 30 min. The desired final dilution was prepared by the addition of PBS.
Trypsin. We used a modification of the method described by Lennette and Schmidt (5) . An amount of 0.5 ml of 0.1 M PBS, pH 7.2, containing 4 mg of trypsin (Difco, 1:250), was added to 1.0 ml of serum at room temperature. This mixture was immediately placed in a 56 C water bath for 30 min, and PBS was then added to produce the desired final dilution.
A fresh trypsin solution was prepared daily.
Dry ice (CO2). Distilled water (0.8 ml) was mixed with 0.1 ml of serum previously heated at 56 C for 30 min. A small pellet of dry ice was then added to this serum. After activity ceased, the resulting precipitate was removed by centrifugation. An amount of 0.1 ml of 8.5% NaCl was added to the supernatant fluid; this made the 1:10 dilution from which the desired dilutions were prepared. 
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Kaolin. A 0.9-ml amount of a 20% suspension of acid-washed kaolin was added to 0.3 ml of serum, and the mixture was shaken every 5 min for 20 min. The kaolin was removed by centrifugation at 1,500 rev/min for 10 min.
Hemagglutination-inhibition (HI) test. Twofold dilutions of serum, with PBS as diluent, were prepared; 0.25 ml was used in each tube. To each tube, 0.25 ml of virus containing four hemagglutination units was added, and the tubes were incubated at 37 C for 1 hr. A 0.5-ml amount of 5% human "O" erythrocytes was then added to each tube. The results were read after incubation at room temperature for 1 hr. Since K104 treatment utilizes KI04, glycerol, and heat, we attempted to determine which of these factors was responsible for the induction of the inhibitor. The results (Table 2) revealed that, of all the various procedures listed, heating the serum for 1 hr at 56 C followed by K104 treatment produced the greatest titer of the inhibitor of B/Singapore/3/64 hemagglutination. The KI04 treatment had no detectable influence on homologous HI titer against A/Equine-2/Miami antigen.
RESULTS
Glycerol alone, K104 alone, and K104 plus glycerol had no detectable effect on hemagglutination of B/Singapore/3/64 virus in the absence of serum. When the same A/Equine-2/Miami antiserum pool was treated by other common procedures (heating plus dry ice, heating plus RDE, and trypsin), no inhibitor was produced against B/ Singapore hemagglutination.
Three different lots of KI04 were tested for their capacity to induce the inhibitor in normal chicken serum. All three lots gave identical results ( Table 3 ). The influence of various concentrations of K104 in the induction of inhibitor in normal chicken serum is also presented in Table 3 . The concentrations that produced the highest titers were 0.033 and 0.011 M. We carried out a study to determine the effects of other procedures commonly used to destroy nonspecific inhibitors on normal chicken serum before and after K104 treatment of the serum. The influence of such treatment on the final resulting titer of the inhibitor with B/Singapore as challenge virus is given in Table 4 .
Our salient observations showed that trypsin and RDE treatment of the serum before K104 treatment prevented the induction of the inhibitor by K104, however, when applied after K104 treatment, destruction of the inhibitor which was induced occurred.
The site of action of the K104-induced inhibitor is unknown. We attempted to determine whether the inhibitor blocks hemagglutination by adsorption onto the virus particles or by adsorption onto the receptor sites on the surface of the erythrocytes. B/Singapore/3/64 influenza virus and a 1:160 dilution of K104-treated normal chicken serum were mixed together and incubated at 37 C for 30 min; the virus was removed by centrifugation in a Spinco ultracentrifuge. The HI activity of the adsorbed serum against B/ Singapore/3/64 virus was then determined. The results indicated that the B/Singapore/3/64 virus removed the K104-induced inhibitor from the serum (Table 5) .
To determine whether the inhibitor was adsorbed onto erythrocytes, 0.2 ml of normal rocytes previously treated with K104-processed serum.
To establish whether the K104-induced inhibitor had any effect on the infectivity of a virus, doubling dilutions (1 :10 to 1:2,560) of periodatetreated normal chicken serum (which had an inhibitor titer against B/Singapore hemagglutination of 1:640) were incubated with an equal volume of B/Singapore virus (560 EIDo) for 1 hr at 37 C. Each of six 10-day-old embryonated chicken eggs was then inoculated in the allantoic sac with 0.2 ml of each dilution of the serum-virus mixture. The eggs were incubated at 35 C for 48 hr and refrigerated overnight; the allantoic fluid was harvested and tested for hemagglutination. All eggs were positive; this indicated that there was no inhibition of infectivity by the chicken serum before or after K104 treatment even at a 1:10 dilution.
Serum from eight adults and six children were tested to determine whether KI04 treatment induced inhibitor in human serum, as well as in chicken serum. The untreated sera had HI titers against B/Singapore virus of 1:20 to 1:80. After K104 treatment, the HI titer of all of the sera had increased to 1:1,280 to 1:2,560.
Other strains of influenza virus reported to be very sensitive to nonspecific inhibitors (M. T 
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Since both chicken and human serum developed 1:320 high titers of inhibitor to B/Singapore hemagglu-1:160 tination after K104 treatment, we tested serum 1:160 samples from several other animal species to 1:160 determine whether this same phenomenon would 1:80 occur. There was great variation among these <1:20 different sera in their capacity to form inhibitor <*___20 as a result of KI04 treatment. The spectrum ranged from human serum, which consistently /170/62, A2/ showed the greatest increase in inhibitor, to B/Taiwan/2/ hamster and mouse serum, neither of which demonstrated a detectable increase in inhibitor treatment of (Table 8) . The effect of RDE and trypsin
In an effort to determine which human serum substrate the periodate converted to inhibitor, preparations of serum albumin (1:10) and -yglobulin (1:100) were titrated for inhibitor after periodate treatment and after RDE treatment. There was no detectable inhibitor induced in the albumin or y-globulin after RDE treatment. However, after periodate treatment, the -y-globulin was not inhibitory, but the serum albumin inhibited B/Singapore virus hemagglutination at 1:640. This suggested that the K104-converted serum albumin into a hemagglutinationinhibitor. The concentration of serum albumin normally found in human serum is 35 mg/ml; therefore, to determine the influence of the concentration on the titer of the K104-induced inhibitor, we treated a series of dilutions of serum albumin with K104 ( Table 9) .
The results demonstrated that the treatment of higher concentrations of serum albumin with K104 produced higher titers of the inhibitor; but, at normal serum levels, an inhibitor with a titer of only 1:80 was induced. These data suggest that another component or components of serum may be acted upon by K104 to induce the usually observed titer of 1:1,280.
The serum albumin from representative animal species whose serum showed high or poor capacity to produce inhibitor by K104 treatment was tested at a concentration of 35 mg/ml before and after K104 treatment. The titers of B/Singapore 
